T1	Participants 524 612	was given SC for 5 days to 60 patients 3 to 30 days after ischemic or hemorrhagic stroke
T2	Participants 870 917	Sixty patients were recruited at mean of 8 days
T3	Participants 988 1016	The groups were well matched
T4	Participants 1074 1115	no significant differences between groups
T5	Participants 1534 1573	from baseline in G-CSF-treated patients
T6	Participants 1584 1600	In 1 participant
T7	Participants 1876 1913	ells in patients with ischemic stroke
